Differential glucocorticoid enhancement of the cytokine-driven transcriptional activation of the human acute phase serum amyloid A genes, SAA1 and SAA2

Journal of Immunology

Volumn 169, Issue 1, 2002, Pages 399-406

  Thorn, Caroline F ^a   Whitehead, Alexander S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; APOLIPOPROTEIN; CYTOKINE; DEXAMETHASONE; GENE PRODUCT; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; LUCIFERASE; MESSENGER RNA; MIFEPRISTONE; PROTEIN SAA1; PROTEIN SAA2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NF IL6; UNCLASSIFIED DRUG;

ACUTE PHASE RESPONSE; ARTICLE; BINDING SITE; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE TIME EFFECT RELATION; ESSENTIAL GENE; GENE CONSTRUCT; GENE DISRUPTION; GENE SEQUENCE; GENE STRUCTURE; GENETIC TRANSFORMATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; QUALITATIVE ANALYSIS; RESIDUE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAA1 GENE; SAA2 GENE; SITE DIRECTED MUTAGENESIS; STEROID METABOLISM; TRANSCRIPTION REGULATION;

EID: 0036644325     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.1.399     Document Type: Article

References (47)

1. The acute phase response
2. Cytokines and the hepatic acute phase response
3. The major acute phase reactants: Creactive protein, serum amyloid P component and serum amyloid A protein
4. Serum amyloid A, the major vertebrate acute-phase reactant
5. Organization of the region encompassing the human serum amyloid A (SAA) gene family on chromosome 11p15.1
6. Nonexpression of the human serum amyloid A three (SAA3) gene
7. Identification of novel members of the serum amyloid A protein superfamily as constitutive apolipoproteins of high density lipoprotein
8. A constitutively expressed serum amyloid A protein gene (SAA4) is closely linked to, and shares structural similarities with, an acute-phase serum amyloid A protein gene (SAA2)
9. Mapping of the mouse serum amyloid A gene cluster by long-range polymerase chain reaction
10. Acute phase proteins in salmonids: Evolutionary analyses and acute phase response
11. Evolution of the serum amyloid A (SAA) protein superfamily
12. Heterogeneous modulation of acute-phase-reactant mRNA levels by interleukin-1β and interleukin-6 in the human hepatoma cell line PLC/PRF/5
13. Expression and regulation of constitutive and acute phase serum amyloid A mRNAs in hepatic and non-hepatic cell lines
14. Human serum amyloid A genes are expressed in monocyte/macrophage cell lines
15. Widespread expression of serum amyloid A in histologically normal human tissues: Predominant localization to the epithelium
16. Serum amyloid A (SAA): The precursor of protein AA in secondary amyloidosis
17. Serum amyloid A-containing human high density lipoprotein 3: Density, size, and apolipoprotein composition
18. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: Implications for serum amyloid A function
19. Serum amyloid A is a chemoattractant: Induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes
20. Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway
21. Serum amyloid A (SAA3) produced by rabbit synovial fibroblasts treated with phorbol esters or interleukin 1 induces synthesis of collagenase and is neutralized with specific antiserum
22. Constitutive and NF-κB-like proteins in the regulation of the serum amyloid A gene by interleukin 1
23. The role of NF-κB and NF-IL6 transactivating factors in the synergistic activation of human serum amyloid A gene expression by interleukin-1 and interleukin-6
24. Use of the acute phase serum amyloid A2 (SAA2) gene promoter in the analysis of pro- and anti-inflammatory mediators: Differential kinetics of SAA2 promoter induction by IL-1/β and TNF-α compared to IL-6
25. Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B cells
26. Heterogeneous nature of the acute phase response: Differential regulation of human serum amyloid A. C-reactive protein, and other acute phase proteins by cytokines in Hep 3B cells
27. Production of serum amyloid A and C-reactive protein by HepG2 cells stimulated with combinations of cytokines or monocyte conditioned media: The effects of prednisolone
28. Variations of serum amyloid A protein and interleukin-6 in patients with low concentration of serum C-reactive protein
29. Relative serum amyloid A (SAA) values: The influence of SAA1 genotypes and corticosteroid treatment in Japanese patients with rheumatoid arthritis
30. Posttranscriptional regulation of acute phase serum amyloid A2 expression by the 5′;- and 3′-untranslated regions of its mRNA
31. Use of a promoterless Renilla luciferase vector as an internal control plasmid for transient co-transfection assays of Ras-mediated transcription activation
32. Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-κB and the glucocorticoid receptor
33. IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein
34. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA
35. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
36. Cooperative effects of C/EBP-like and NF-κB-like binding sites on rat serum amyloid A1 gene expression in liver cells
37. YY1 represses rat serum amyloid A1 gene transcription and is antagonized by NF-κB during acute-phase response
38. Purification and identification of a tissue-specific repressor involved in serum amyloid Al gene expression
39. NFκB interacts with serum amyloid A3 enhancer factor to synergistically activate mouse serum amyloid A3 gene transcription
40. Isolation and functional characterization of cDNA of serum amyloid A-activating factor that binds to the serum amyloid A promoter
41. Activation of Sp1 and its functional co-operation with serum amyloid A-activating sequence binding factor in synoviocyte cells trigger synergistic action of interleukin-1 and interleukin-6 in serum amyloid A gene expression
42. The glucocorticoid receptor binds to defined nucleotide sequences near the promoter of mouse mammary tumour virus
43. Interaction of cytokine and glucocorticoid-response elements of acute-phase plasma protein genes: Importance of glucocorticoid receptor level and cell type for regulation of the elements from rat αI-acid glycoprotein and β-fibrinogen genes
44. Characterization of amyloid A protein in human secondary amyloidosis: The predominant deposition of serum amyloid A1
45. Serum amyloid A secretion from monocytic leukaemia cell line THP-1 and cultured human peripheral monocytes
46. Dexamethasone, but not IL-1 alone, upregulates acute-phase serum amyloid Al gene expression and production by cultured human aortic smooth muscle cells
47. In vitro evaluation of an enhanced human serum amyloid A (SAA2) promoter-regulated soluble TNF receptor fusion protein